Curemeta LLC is a Boston-based company dedicated to the development of therapeutic antibodies and cancer drugs, with a specific focus on aggressive and metastatic cancers.
With a mission to provide meaningful treatments and cures for patients, Curemeta aims to generate novel cancer targets and develop innovative drugs to combat metastatic cancer by the year 2022.
Generated from the website